“[R]etention [of gadolinium-based contrast agents] in the skin and bone is much greater than in the brain,” Karen Bleich, M.D., Division of Medical Imaging Products, September 8, 2017FDA MIDAC meeting, https://t.co/zpEH5loVHF
“There have also been reports of gadolinium-associated plaques... there have now been three reported cases where the patients did not have [‘nephrogenic’ systemic fibrosis], and one of those three cases did not have renal disease,” Karen Bleich, M.D., September 8, 2017 FDA MIDAC
Some patients report horrible adverse effects (thought to be from #Gadolinium deposition) after receiving #MRI Contrast. There are consistent reports of NO help from their healthcare system afterwards.
Q: Which institutions are abandoning these pts after administering #GBCA?
@newscentermaine They Stayed Silent and are Still Silent after My Daughter was Hit and My Son was Molested the Police are just as Much as a Joke Funny No one read Dr Ricci 15 page Report Clearly Stating it Happened
@SGottliebFDA @SecAzar @HHSMedia What about the 10's of Thousands of us Suffering From Your 30 Clinical Human Trial of Gadolinium , When do We get Help ?
Which gadolinium-based contrast agents enter the brain? “[I]t was soon demonstrated that it was all of the agents,” Karen Bleich, M.D., Division of Medical Imaging Products, September 8, 2017 FDA MIDAC meeting, https://t.co/awj7aWAeJ9
#gadolinium#reten… https://t.co/78ap1dYyo2
In Texas, prepping for an interview with @chucknorris and wife Gena on their fight to win justice for those harmed by a dye used in many MRI tests. We'll let you know when the story is ready to run. @FullMeasureNews@SharylAttkisson
“As a reminder, it took nine years to link [‘nephrogenic’ systemic fibrosis] with the gadolinium,” Pierre Desche, Guerbet, Sep 8, 2017 FDA MIDAC meeting, https://t.co/zpEH5lGx6f